
BBU Stock Forecast & Price Target
BBU Analyst Ratings
Bulls say
Brookfield Business Partners LP has demonstrated strong financial performance across its business segments, with notable contributions from Clarios, which reported an EBITDA of US$275 million, reflecting an 11% sequential increase and 8% year-over-year growth. Additionally, the company's Industrial Operations segment exhibited robust results, achieving an EBITDA of US$354 million, exceeding forecasts and marking a sequential increase of 12% and a year-over-year rise of 15.7%. Furthermore, the strong operating momentum in the residential mortgage insurance sector, highlighted by a 26% sequential rise in EBITDA from Sagen MI Canada, reinforces the company's overall positive outlook and growth potential.
Bears say
Brookfield Business Partners LP is facing significant financial challenges, as evidenced by a notable decline in EBITDA from its CDK Global segment, experiencing a decrease of approximately 10% quarter-over-quarter and 36% year-over-year. In addition, DexKo reported a substantial 33% drop in EBITDA, which reflects broader weaknesses within the company's revenue-generating segments. Furthermore, an anticipated compression of EV/EBITDA multiples across its key operational divisions due to underperformance of underlying investments adds to the negative outlook surrounding the company's financial health.
This aggregate rating is based on analysts' research of Brookfield Business Partners and is not a guaranteed prediction by Public.com or investment advice.
BBU Analyst Forecast & Price Prediction
Start investing in BBU
Order type
Buy in
Order amount
Est. shares
0 shares